WB demonstrated that the expression level of mTOR showed a decreasing trend in ccRCC compared with adjacent specimens (P = 0.077, Fig. 1), which was consistent with its mRNA expression (Fan et al., 2020). This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.